Read + Share
Matulonis UA. The rapid evolution of PARP inhibitor therapy for advanced ovarian cancer:
Lessons being learned and new questions emerging from phase 3 trial long-term
outcome data. Gynecol Oncol 2022;167:401-403.
PMID: 36494142
|
 |
|
Matulonis UA. The rapid evolution of PARP inhibitor therapy for advanced ovarian cancer:
Lessons being learned and new questions emerging from phase 3 trial long-term
outcome data. Gynecol Oncol 2022;167:401-403.
PMID: 36494142
|
|
|
|